About Louis Shamel

Core Competencies

Career history

• Louis Shamel Consulting — Strategic Pricing Lead (June 2024–Present)

  Client: Genesee Scientific — Primary pricing strategy and analytics resource for finance, marketing, and sales teams. Led pricing and margin optimization initiatives within a distribution environment, supporting finance and sales with price performance reporting, profitability analytics, and annual/intra-year pricing actions. Developed price scraping software to establish price history database to inform decision making.

• Thermo Fisher Scientific — Sr. Director, Global Strategic Pricing (October 2020–April 2024)

  Co-head of the Global Strategic Pricing function overseeing pricing strategies for $5-10B life sciences segments. Led development and operation of enterprise pricing and profitability decision systems using technology-enabled processes and data-driven insights. Partnered with data science, IT, and analytics teams to define and deliver pricing technology roadmap, including digital solutions supporting revenue growth, margin optimization, and deal execution. Adapted commercial and product pricing strategies to dynamic COVID and post-COVID market conditions.

• Thermo Fisher Scientific — Director, Global Strategic Pricing (February 2017–October 2020)

  Deployed web platform to coordinate annual list price renewal alignment globally across four divisions. Developed and executed dynamic price recommendation system into Sales Force.com/CPQ quoting system.

• Thermo Fisher Scientific — Sr. Manager, Global Strategic Pricing (July 2015–February 2017)

  Led team of 4 pricing analysts to execute pricing strategies for the Bioscience Division globally and for all divisions in North America. Drove implementation of best practices, supporting achievement of $33M global price attainment for Biosciences Division and $39M in North America in 2016. Led deployment of web application for renewing list pricing guided by analytics, increasing transparency and reducing time for resource-intensive global annual process.

• Thermo Fisher Scientific — Lead Analyst & Manager, M&A (2010–2015)

  Led and supported domestic and international M&A transactions ranging from $1M to $1.5B, including financial modeling, business case development, and executive reporting. Managed cross-functional due diligence and integration planning across finance, operations, IT, HR, legal, and commercial teams.

• Earlier life sciences roles

  Research and business development positions at Scripps Research Institute, Gen-Probe, Illumina, The Salk Institute, and Althea Technologies—spanning genetics, bioinformatics, product development, and portfolio analytics.